Indolizine derivatives, composition and methods of use
US10894038B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 26, 2016 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | Jun 29, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.